Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Insmed Inc.
Headquarters: Bridgewater, NJ, United States of America
Website: http://www.insmed.com
Year Founded: 1988
Status: Public
Industry Sector: HealthTechnology
CEO: Will Lewis, MBA
Number Of Employees: 1,271
Enterprise Value: $11,205,823,720
PE Ratio: -13.66
Exchange/Ticker 1: NASDAQ:INSM
Exchange/Ticker 2: N/A
Latest Market Cap: $13,808,413,696
BioCentury | Jan 29, 2025
Guest Commentary
Winning over Wall Street: Biotechs’ comeback playbook — a Guest Commentary by Jami Rubin
Advice for CEOs and CFOs as they navigate the year ahead
BioCentury | Jul 9, 2024
Finance
2Q24 Wrap: Trickle down recovery?
Biopharmas above $5B in market cap are up, but everyone else languishes
BioCentury | May 31, 2024
Finance
Public Equity Report: Insmed, Merus raise combined $1B+ after readouts
Plus: PIPEs help Celcuity, Cargo advance clinical programs
BioCentury | May 30, 2024
Product Development
Clinical Report: Phase III win for J&J in neuropsychiatry; Biohaven falls on BHV-1300 data
Plus: Insmed gets boost from bronchiectasis readout and updates from HI-Bio, Corcept, Tango and Ikena
BioCentury | Jan 10, 2024
Management Tracks
Mark Alles at the helm at Torl
Plus: new CSO at Nutcracker, and updates from
BioCentury | Sep 5, 2023
Deals
Sept. 5 Quick Takes: Moulder’s Zenas in regional deal with BMS for bispecific
Plus: Beam moves base editors into the clinic and updates on Star, Tivdak, Olema and Insmed’s Arikayce
BioCentury | Nov 28, 2022
Management Tracks
Biosplice’s Beaupre becomes CMO at Ideaya
Plus: Blaine Davis named CFO at Selecta, and updates from Promontory, ARTHEx and Shionogi
BioCentury | Sep 30, 2022
Management Tracks
Sullivan becomes CBO at Prilenia
Plus new CMO at Cellectis, and updates from Lyell, Adrestia, Mursla and more
BioCentury | May 24, 2022
Management Tracks
Ascendis names new commercial heads as Høiland retires
Plus Insmed names Wise CCO, and updates from Element,
BioCentury | Jan 20, 2022
Management Tracks
GSK’s Thirsk joins Bavarian Nordic as COO
Plus Baroldi, Bastings join Ionis, and updates from Exscientia,
Items per page:
1 - 10 of 256